The prevalence of primary hypertension (HTN) in children has increased significantly, a public health phenomenon that parallels the current childhood obesity epidemic. This increase in childhood primary HTN foreshadows an impending epidemic of premature cerebrovascular and cardiovascular disease. Already there is evidence that HTN in adolescence and young adulthood is associated with cognitive decline and stroke in midlife and beyond. However, there are significant evidence gaps regarding the current approach to treatment of pediatric HTN, largely because HTN-associated events, such as stroke, occur in later decades, making outcomes based treatment guidelines elusive. One strategy is to use early biomarkers of hypertensive target organ damage (TOD) to predict clinical outcomes. However, reliable biomarkers of hypertensive TOD to the brain in youth are lacking. Our goal is to identify and evaluate early biomarkers of TOD to the brain to help focus studies on HTN treatment, and eventually modify the trajectory of HTN-induced morbidity. Our previous results showing decreased neurocognitive test performance in HTN youth suggest that treating HTN beginning in adolescence represents an opportunity to reduce subsequent cognitive decline and dementia later in life, heretofore an elusive goal. However, the degree of structural brain injury in HTN youth and its reversibility are not known. We now propose to study white matter microstructural integrity using diffusion magnetic resonance imaging (dMRI) as an anatomic correlate of hypertensive TOD to the brain in adolescents. The presence of altered white matter integrity could serve as a novel biomarker of hypertensive TOD to the brain in youth and could provide a pathomechanistic link between adolescent HTN and subsequent cognitive outcomes. In combination with neurocognitive testing, dMRI findings would serve as study outcomes to allow practical longitudinal research on the effect of early HTN treatment on the brain in adolescence and beyond. We propose to compare dMRI metrics of untreated, newly diagnosed hypertensive adolescents to that of matched normotensive controls. As secondary measures, we will also assess the impact of HTN on vascular reactivity and functional connectivity via resting state functional MRI. We will evaluate the association between altered dMRI metrics and HTN severity, and we will evaluate the correlation between neuroimaging parameters and neurocognitive test performance. In an observational exploratory aim, we will determine if there are longitudinal changes in neuroimaging parameters after 18 months of usual care antihypertensive therapy in newly diagnosed HTN subjects. This proposal represents a logical and innovative extension of our work and will lay critical groundwork for the development of evidence-based treatment guidelines to improve downstream cognitive outcomes.

Public Health Relevance

High blood pressure in childhood has become a common problem, in large part due to the obesity epidemic in children. This project investigates a possible new way that high blood pressure may adversely affect children's health, namely by causing subtle damage to the nerve cells that make up the brain. Given the growing number of children with high blood pressure, this project will have a significant impact on public health by defining the impact of high blood pressure on the nerve cells of the brain in these children and by beginning to determine to what extent these problems are reversible with medication to lower blood pressure.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL098332-08
Application #
10078957
Study Section
Biobehavioral Mechanisms of Emotion, Stress and Health Study Section (MESH)
Program Officer
Einhorn, Paula T
Project Start
2010-08-14
Project End
2023-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
8
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Rochester
Department
Pediatrics
Type
School of Medicine & Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Hinkle, Jane; Connolly, Heidi V; Adams, Heather R et al. (2018) Severe obstructive sleep apnea in children with elevated blood pressure. J Am Soc Hypertens 12:204-210
Lande, Marc B; Batisky, Donald L; Kupferman, Juan C et al. (2018) Neurocognitive Function in Children with Primary Hypertension after Initiation of Antihypertensive Therapy. J Pediatr 195:85-94.e1
Kupferman, Juan C; Batisky, Donald L; Samuels, Joshua et al. (2018) Ambulatory blood pressure monitoring and neurocognitive function in children with primary hypertension. Pediatr Nephrol 33:1765-1771
Lande, Marc B; Batisky, Donald L; Kupferman, Juan C et al. (2017) Neurocognitive Function in Children with Primary Hypertension. J Pediatr 180:148-155.e1
Lande, Marc B; Mendley, Susan R; Matheson, Matthew B et al. (2016) Association of blood pressure variability and neurocognition in children with chronic kidney disease. Pediatr Nephrol 31:2137-44
Kisser, Jason E; Allen, Allyssa J; Katzel, Leslie I et al. (2016) Relations of blood pressure and head injury to regional cerebral blood flow. J Neurol Sci 365:9-14
Lande, Marc B; Kupferman, Juan C (2015) Cognitive function in hypertensive children. Curr Hypertens Rep 17:508
Taasoobshirazi, Katayun; Batisky, Donald L (2015) When listening for hoofbeats, sometimes there are zebras-an interesting case of a teenager with edema and high blood pressure: Answers. Pediatr Nephrol 30:927-9
Lande, Marc B; Hooper, Stephen R; Batisky, Donald L et al. (2015) Sleep disordered breathing as measured by SRBD-PSQ and neurocognition in children with hypertension. Am J Hypertens 28:552-8
Lande, Marc B; Kupferman, Juan C (2014) Pediatric hypertension: the year in review. Clin Pediatr (Phila) 53:315-9

Showing the most recent 10 out of 17 publications